Claims directed to method of detecting a mutation in dog DNA held patent ineligible under §101

On August 9, 2019, the US Court of Appeals for the Federal Circuit so held.  The patent covered ways to genotype Labrador Retrievers for the presence of a mutation in the SUV39H2 gene associated with Hereditary Nasal Parakeratosis (HNPK).  The invalidated claims were directed to methods of genotyping and required only obtaining a biological sample, genotyping a SUV39H2 gene and detecting the presence of the mutation.  A corresponding European patent was granted and unopposed.  genetic-veterinary-sciences-v-lanoklin-gmbh